News Covid-19: Valneva’s vaccine produces stronger immune response than AstraZeneca’s, company reports BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2551 (Published 18 October 2021) Cite this as: BMJ 2021;375:n2551 Read our latest coverage of the coronavirus pandemic Article Related content Metrics Responses Peer review Related articles Feature Covid-19: What next for the Valneva vaccine? Published: 23 November 2021; BMJ 375 doi:10.1136/bmj.n2839 News Covid-19: UK approves Valneva vaccine for adults under 50 Published: 14 April 2022; BMJ 377 doi:10.1136/bmj.o985 See more Introductory Address Prov Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1 Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond's Prov Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10 Mr. Warburton's Bill for the Regulation of the Medical Profession Prov Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13 An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive Letterpress Prov Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4 A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &c Prov Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a Cited by... Covid-19: UK approves Valneva vaccine for adults under 50Fulltext PDF Covid-19: What next for the Valneva vaccine?Fulltext PDF